GaviLyte-N Interactions
There are 396 drugs known to interact with GaviLyte-N (polyethylene glycol 3350 with electrolytes), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 360 are moderate, and 1 is minor.
- View all 396 medications that may interact with GaviLyte-N
- View GaviLyte-N alcohol/food interactions (1)
- View GaviLyte-N disease interactions (7)
Most frequently checked interactions
View interaction reports for GaviLyte-N (polyethylene glycol 3350 with electrolytes) and the medicines listed below.
- acetaminophen
- Advil (ibuprofen)
- albuterol
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- Asmanex HFA (mometasone)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- atorvastatin
- Benadryl (diphenhydramine)
- benzonatate
- cephalexin
- ciprofloxacin
- clindamycin
- colchicine
- diclofenac topical
- doxycycline
- Eliquis (apixaban)
- hydrocodone
- levothyroxine
- lisinopril
- Lyrica (pregabalin)
- melatonin
- oxycodone
- pantoprazole
- pravastatin
- prednisone
- sotalol
- Tylenol (acetaminophen)
GaviLyte-N alcohol/food interactions
There is 1 alcohol/food interaction with GaviLyte-N (polyethylene glycol 3350 with electrolytes).
GaviLyte-N disease interactions
There are 7 disease interactions with GaviLyte-N (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
Report options
More about GaviLyte-N (polyethylene glycol 3350 with electrolytes)
- GaviLyte-N consumer information
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: laxatives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.